Although the current results indicate no significant difference in the effect of immunosuppressants in STS patients with different TROAP expressions, this may be due to the lack of more cohort data on immunotherapy for STS, and a larger STS cohort in the future is needed for further validation. Here, TROAP is linked to telomere syndrome.